Charles River Laboratories International (CRL) Non-Current Deferred Tax Liability (2010 - 2025)

Charles River Laboratories International (CRL) has reported Non-Current Deferred Tax Liability for 14 consecutive years, with $95.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability fell 10.99% year-over-year to $95.2 million; the TTM figure through Dec 2025 stood at $95.2 million (down 10.99% YoY), while the FY2025 annual figure was $95.2 million, down 10.99% from the prior year.
• Non-Current Deferred Tax Liability came in at $95.2 million for Q4 2025 at Charles River Laboratories International, down from $123.0 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $420.6 million in Q4 2021, with the low at $95.2 million in Q4 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $193.6 million, with a median of $193.7 million recorded in 2022.
• Across the five-year window, Non-Current Deferred Tax Liability surged 30.12% in 2021 and sank 48.74% in 2022, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $420.6 million in 2021, then tumbled by 48.74% to $215.6 million in 2022, then slipped by 11.24% to $191.3 million in 2023, then slumped by 44.1% to $107.0 million in 2024, then declined by 10.99% to $95.2 million in 2025.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $95.2 million, $123.0 million, and $109.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.